P Falagiani1. Show Affiliations » 1. Scientific Director, Lofarma S.p.A., Milan, Italy. paolo.falagiani@lofarma.it
Abstract
Entities: Chemical
Mesh: See more » AnimalsClinical Trials as TopicDesensitization, Immunologic/methodsDisease Models, AnimalHumansHypersensitivity/therapyNickel/administration & dosageNickel/immunologyNickel/therapeutic useT-Lymphocytes, Regulatory/immunology
Substances: See more » Nickel
Year: 2005 PMID: 17761097
Source DB: PubMed Journal: Int J Immunopathol Pharmacol ISSN: 0394-6320 Impact factor: 3.219